SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-016132
Filing Date
2018-11-14
Accepted
2018-11-14 16:33:14
Documents
76
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 692660
2 ex31-1.htm EX-31.1 19218
3 ex31-2.htm EX-31.2 19828
4 ex32-1.htm EX-32.1 7760
5 ex32-2.htm EX-32.2 7877
  Complete submission text file 0001493152-18-016132.txt   3775236

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE idxg-20180930.xml EX-101.INS 663490
7 XBRL SCHEMA FILE idxg-20180930.xsd EX-101.SCH 44906
8 XBRL CALCULATION FILE idxg-20180930_cal.xml EX-101.CAL 65852
9 XBRL DEFINITION FILE idxg-20180930_def.xml EX-101.DEF 156557
10 XBRL LABEL FILE idxg-20180930_lab.xml EX-101.LAB 291232
11 XBRL PRESENTATION FILE idxg-20180930_pre.xml EX-101.PRE 252580
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
Interpace Diagnostics Group, Inc. (Filer) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24249 | Film No.: 181184458
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10